Formulation and Design of Probiotic Supplements for Rheumatoid Arthritis Patients

Background: Probiotics are live microorganisms with immune-regulatory properties and may be useful for patients suffering from rheumatoid arthritis (RA), an autoimmune inflammatory disorder. The aim of the present study was to formulate L. casei 01 capsules at laboratory scale, and evaluate its effects on the proportion of T-helper type 2 (Th2) anti-inflammatory cytokines to T-helper type 1 (Th1) pro-inflammatory cytokines (Th2/Th1), in RA patients. Methods: After blending the probiotic and excipient (maltodextrin) based on the relevant calculations, the content uniformity of the mixture was evaluated. Furthermore, viability of the probiotic bacteria was assessed during capsules production and throughout three months of storage. In a randomized double-blind placebo-controlled trial, 46 RA patients were supplemented with either the capsules (containing at least 108 CFU of Lactobacillus. casei 01) or placebo (maltodextrin), for eight weeks; DAS28 (Disease activity score 28) as well as serum inflammatory cytokines (TNF-α, IL-1β, IL-6, IL-10 and IL-12) were measured at baseline and the end of study. IL-10/IL-1β, IL-10/IL-6, IL-10/IL-12, IL10/TNF-α and IL-10/(IL-1β+ IL-6+ IL-12+ TNF-α) were calculated, the latter being expressed as IL-10/total Th1, and compared for the groups. Paired samples t test, Wilcoxon signed-rank test and ANCOVA tests were applied. Results: Probiotic powder had been uniformly mixed with the excipient and the bacteria had acceptable viability throughout the study course. Supplementation of RA patients with the capsules resulted in a significant decrease in disease activity (DAS28, P=0.039) and increase in IL-10/TNF-α, IL-10/IL-12 and IL-10/total Th1 (P=0.039, P=0.012 and P=0.014, respectively). At the end of the study, there was a significant difference between the two groups in terms of IL-10/IL-12 and IL-10/total Th1 (P= 0.038 and P= 0.006, respectively). Conclusion: L. casei 01 supplements may have the expected desired anti-inflammatory effects in RA patients. Further clinical trials are warranted to confirm these results.

[1]  M. Asghari-Jafarabadi,et al.  Probiotic supplementation improves inflammatory status in patients with rheumatoid arthritis. , 2014, Nutrition.

[2]  Aziz Homayouni Rad,et al.  Might patients with immune-related diseases benefit from probiotics? , 2013, Nutrition.

[3]  Mina Javadi,et al.  Do probiotics act more efficiently in foods than in supplements? , 2012, Nutrition.

[4]  Roman Teimer,et al.  Influence of Dietary Components on Regulatory T Cells , 2012, Molecular medicine.

[5]  A. H. Rad,et al.  A SURVEY TO INCREASING THE PROBIOTIC SURVIVAL IN FUNCTIONAL ICE CREAM BY MICROENCAPSULATION , 2012 .

[6]  R. P. Ross,et al.  Recommendations for the viability assessment of probiotics as concentrated cultures and in food matrices. , 2011, International journal of food microbiology.

[7]  G. Reid,et al.  A randomized, double-blinded, placebo-controlled pilot study of probiotics in active rheumatoid arthritis , 2011, Medical science monitor : international medical journal of experimental and clinical research.

[8]  Poonam Sharma,et al.  Lactobacillus casei reduces the Inflammatory Joint Damage Associated with Collagen-Induced Arthritis (CIA) by Reducing the Pro-Inflammatory Cytokines , 2011, Journal of Clinical Immunology.

[9]  David R Mandel,et al.  Bacillus coagulans: a viable adjunct therapy for relieving symptoms of rheumatoid arthritis according to a randomized, controlled trial , 2010, BMC complementary and alternative medicine.

[10]  K. Peng,et al.  Preferential promotion of apoptosis of monocytes by Lactobacillus casei rhamnosus soluble factors. , 2009, Clinical nutrition.

[11]  E. Chan,et al.  A standard quantitative method to measure acid tolerance of probiotic cells , 2010, Applied Microbiology and Biotechnology.

[12]  J. Villena,et al.  Lactobacillus casei modulates the inflammation-coagulation interaction in a pneumococcal pneumonia experimental model , 2009, Journal of Inflammation.

[13]  M. Gershwin,et al.  Probiotics and immunity , 2009, Journal of Gastroenterology.

[14]  M. Ehsani,et al.  Effect of microencapsulation and resistant starch on the probiotic survival and sensory properties of synbiotic ice cream , 2008 .

[15]  S. Im,et al.  Lactobacillus casei potentiates induction of oral tolerance in experimental arthritis. , 2008, Molecular immunology.

[16]  S. Im,et al.  Lactobacillus casei suppresses experimental arthritis by down-regulating T helper 1 effector functions. , 2008, Molecular immunology.

[17]  D. Martel,et al.  Immunomodulatory effects of probiotics in the intestinal tract. , 2008, Current issues in molecular biology.

[18]  Harjinder Singh,et al.  Recent advances in microencapsulation of probiotics for industrial applications and targeted delivery , 2007 .

[19]  W. Walker,et al.  Bacterial colonization, probiotics, and clinical disease , 2006 .

[20]  J. Villena,et al.  Beneficial immunomodulatory activity of Lactobacillus casei in malnourished mice pneumonia: effect on inflammation and coagulation. , 2006, Nutrition.

[21]  N. Borruel,et al.  Modulation of apoptosis in intestinal lymphocytes by a probiotic bacteria in Crohn's disease , 2006, Journal of leukocyte biology.

[22]  E. Knol,et al.  Identification of strong interleukin‐10 inducing lactic acid bacteria which down‐regulate T helper type 2 cytokines , 2005, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[23]  J. Neu,et al.  Alive and dead Lactobacillus rhamnosus GG decrease tumor necrosis factor-alpha-induced interleukin-8 production in Caco-2 cells. , 2005, The Journal of nutrition.

[24]  M. Yazdanbakhsh,et al.  Selective probiotic bacteria induce IL-10-producing regulatory T cells in vitro by modulating dendritic cell function through dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin. , 2005, The Journal of allergy and clinical immunology.

[25]  M. Sata,et al.  Probiotic Lactobacillus‐induced improvement in murine chronic inflammatory bowel disease is associated with the down‐regulation of pro‐inflammatory cytokines in lamina propria mononuclear cells , 2005, Clinical and experimental immunology.

[26]  A. Beynen,et al.  Monostrain, multistrain and multispecies probiotics--A comparison of functionality and efficacy. , 2004, International journal of food microbiology.

[27]  R. Korpela,et al.  Effects of probiotic therapy on the activity and activation of mild rheumatoid arthritis – a pilot study , 2003, Scandinavian journal of rheumatology.

[28]  M. Médici,et al.  Interaction of lactic acid bacteria with the gut immune system , 2002, European Journal of Clinical Nutrition.

[29]  T. Mattila-Sandholm,et al.  Gut bacteria and health foods--the European perspective. , 2002, International journal of food microbiology.

[30]  P. Gopal,et al.  Enhancement of immunity in the elderly by dietary supplementation with the probiotic Bifidobacterium lactis HN019. , 2001, The American journal of clinical nutrition.

[31]  T. Yokokura,et al.  Suppressive effects of the oral administration of Lactobacillus casei on type II collagen-induced arthritis in DBA/1 mice. , 1998, Life sciences.

[32]  O. Hänninen,et al.  Faecal microbial flora and disease activity in rheumatoid arthritis during a vegan diet. , 1997, British journal of rheumatology.

[33]  P. Hannonen,et al.  Intestinal flora in early rheumatoid arthritis. , 1994, British journal of rheumatology.

[34]  G. Rook,et al.  Rheumatoid arthritis: how well do the theories fit the evidence? , 1993, Clinical and experimental immunology.

[35]  V. Wright,et al.  Comparison of faecal florae in patients with rheumatoid arthritis and controls. , 1987, British journal of rheumatology.